Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

被引：0
|
作者：
Hubert G. Nüßlein
Rieke Alten
Mauro Galeazzi
Hanns-Martin Lorenz
Michael T. Nurmohamed
William G. Bensen
Gerd R. Burmester
Hans-Hartmut Peter
Karel Pavelka
Melanie Chartier
Coralie Poncet
Christiane Rauch
Manuela Le Bars
机构：
[1] University of Erlangen-Nuremberg,Institute of Rheumatology and Clinic of Rheumatology
[2] Schlosspark-Klinik University Medicine,undefined
[3] University of Siena,undefined
[4] University Hospital,undefined
[5] VU University Medical Center/Jan van Breeman Research Institute,undefined
[6] St Joseph’s Hospital/McMaster University,undefined
[7] Charité-Universitätsmedizin,undefined
[8] University Medical Center Freiburg,undefined
[9] Charles University,undefined
[10] Chiltern International,undefined
[11] Docs International,undefined
[12] Bristol‐Myers Squibb,undefined
[13] Bristol-Myers Squibb,undefined
来源：
BMC Musculoskeletal Disorders | / 16卷
关键词：
Abatacept; Biologic agents; Cyclic citrullinated peptide; Heart failure; Prognostic factors; Multivariate analysis; Retention; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study
    Nuesslein, Hubert G.
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Nurmohamed, Michael T.
    Bensen, William G.
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [2] Prognostic Factors for IV Abatacept Retention in Patients Who Have Received at Least One Prior Biologic Agent: 2-Year Results from a Prospective, International, Real-World Study
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H. M.
    Nurmohamed, M. T.
    Bensen, W. G.
    Burmester, Gerd
    Peter, H-H
    Peichl, P.
    Pavelka, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1087 - S1088
  • [3] PROGNOSTIC FACTORS FOR INTRAVENOUS ABATACEPT RETENTION IN PATIENTS WHO HAVE RECEIVED AT LEAST ONE PRIOR BIOLOGIC AGENT: 2-YEAR RESULTS FROM A PROSPECTIVE, INTERNATIONAL, REAL-WORLD STUDY
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Nurmohamed, Michael T.
    Bensen, William G.
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Peichl, Peter
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. RHEUMATOLOGY, 2015, 54 : 77 - 78
  • [4] Body Mass Index Does Not Impact Abatacept Retention in Biologic-Naive Patients with Rheumatoid Arthritis Who Have Poor Prognostic Factors: A 12-Month Interim Analysis of an Observational, Prospective Study
    Alten, R.
    Lorenz, H-M
    Nusslein, H. G.
    Mariette, X.
    Galeazzi, M.
    Cantagrel, A.
    Chartier, M.
    Elbez, Y.
    Rauch, C.
    Le Bars, M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] Does Body Mass Index Impact Long-Term Retention with Abatacept in Patients with RA Who Have Received at Least One Prior Biologic Agent? 2-Year Results from a Real-World, International, Prospective Study
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H. M.
    Nurmohamed, M. T.
    Bensen, W. G.
    Burmester, Gerd
    Peter, H-H
    Peichl, P.
    Pavelka, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1088 - S1089
  • [6] DOES BODY MASS INDEX IMPACT LONG-TERM RETENTION WITH ABATACEPT IN PATIENTS WITH RA WHO HAVE RECEIVED AT LEAST ONE PRIOR BIOLOGIC AGENT? 2-YEAR RESULTS FROM A REAL-WORLD, INTERNATIONAL, PROSPECTIVE STUDY
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H.
    Nurmohamed, M.
    Benson, W.
    Burmester, G.
    Peter, H.
    Peichl, P.
    Pavelka, P.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 : 31 - 32
  • [7] DOES BODY MASS INDEX IMPACT LONG-TERM RETENTION WITH ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE RECEIVED AT LEAST ONE PRIOR BIOLOGIC AGENT? 2-YEAR RESULTS FROM A REAL-WORLD, INTERNATIONAL, PROSPECTIVE STUDY
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Nurmohamed, Michael T.
    Bensen, William G.
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Peichl, Peter
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. RHEUMATOLOGY, 2015, 54 : 186 - 187
  • [8] Body Mass Index does not Impact Abatacept Retention in BiologicNaive Patients with Rheumatoid Arthritis who have Poor Prognostic Factors: A 12-Month Interim Analysis of an Observational, Prospective Study
    Alten, Rieke
    Lorenz, Hannes
    Nuesslein, Hubert
    Mariette, Xavier
    Galeazzi, Mauro
    Cantagrel, Alain
    Chartier, Melanie
    Elbez, Yedid
    Rauch, Christiane
    Le Bars, Manuela
    Muratti, Eleonora
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 892 - 893
  • [9] PREDICTORS OF RETENTION WITH ABATACEPT IN PATIENTS WHO HAVE FAILED ONE OR MORE BIOLOGIC AGENTS: RESULTS FROM THE INTERNATIONAL, REAL-WORLD ACTION STUDY
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Maurizio
    Lorenz, Hannes M.
    Nurmohamed, Michael T.
    Bensen, William
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. RHEUMATOLOGY, 2014, 53 : 94 - 95
  • [10] Predictors of retention with abatacept in patients who have failed one or more biologic agents: results from the international, real-world ACTION study
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H.
    Boumpas, D.
    Nurmohamed, M.
    Bensen, W.
    Burmester, G.
    Peter, H.
    Rainer, F.
    Pavelka, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    LeBars, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 108 - 108
12345